On March 8, 2024, Brian Cahill resigned from his position as Chief Financial Officer of Eagle Pharmaceuticals, Inc. (the ?Company?), effective immediately. The Board of Directors of the Company (the ?Board?) has instituted a search for Mr. Cahill?s successor as Chief Financial Officer. In connection with Mr. Cahill?s separation, Steven Ratoff, a member of the Board and Chair of the Audit Committee of the Board (the ?Audit Committee?), was appointed Interim Chief Financial Officer of the Company, effective immediately, to serve until such time as a new Chief Financial Officer commences employment or such other date determined by the Board or upon his earlier resignation.

Mr. Ratoff remains a member of the Board. Mr. Ratoff has served as a member of the Board since March 2007. Mr. Ratoff has served as the Chief Executive Officer of CM Systems LLC, since July 2018.

Mr. Ratoff?s prior experience includes serving as a Venture Partner for ProQuest Investments from 2005 to 2013, as Chief Executive Officer of Novadel Pharma, Inc., from 2007 to 2012, and as Chief Executive Officer of CIMA Labs, Inc. In addition, Mr. Ratoff served as Chief Financial Officer of the Brown-Forman Company from 1995 to 2001. Mr. Ratoff holds a B.S. in business administration from Boston University and an M.B.A. with Distinction from the University of Michigan.